Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Boehringer Ingelheim
Colorcon
Mallinckrodt
Dow

Last Updated: January 25, 2022

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050641


Email this page to a colleague

« Back to Dashboard

NDA 050641 describes MONODOX, which is a drug marketed by Chartwell Rx and is included in one NDA. It is available from two suppliers. Additional details are available on the MONODOX profile page.

The generic ingredient in MONODOX is doxycycline. There are twenty-eight drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the doxycycline profile page.
Summary for 050641
Tradename:MONODOX
Applicant:Chartwell Rx
Ingredient:doxycycline
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 050641
Medical Subject Heading (MeSH) Categories for 050641
Suppliers and Packaging for NDA: 050641
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MONODOX doxycycline CAPSULE;ORAL 050641 NDA AUTHORIZED GENERIC RPK Pharmaceuticals, Inc. 53002-0671 53002-0671-0 100 CAPSULE in 1 BOTTLE (53002-0671-0)
MONODOX doxycycline CAPSULE;ORAL 050641 NDA AUTHORIZED GENERIC RPK Pharmaceuticals, Inc. 53002-0671 53002-0671-1 2 CAPSULE in 1 BOTTLE (53002-0671-1)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 100MG BASE
Approval Date:Dec 29, 1989TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 50MG BASE
Approval Date:Feb 10, 1992TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 75MG BASE
Approval Date:Oct 18, 2006TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
AstraZeneca
Johnson and Johnson
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.